65-4107. (a) The controlled substances listed in this section are included in schedule II and the number set forth opposite each drug or substance is the DEA controlled substances code which has been assigned to it.
(b) Any of the following substances, except those narcotic drugs listed in other schedules, whether produced directly or indirectly by extraction from substances of vegetable origin or independently by means of chemical synthesis or by combination of extraction and chemical synthesis:
(1) Opium and opiate and any salt, compound, derivative or preparation of opium or opiate, excluding apomorphine, dextrorphan, nalbuphine, nalmefene, naloxone, 6β-naltrexol and naltrexone and their respective salts, but including the following:
(A) |
Raw opium |
9600 |
(B) |
Opium extracts |
9610 |
(C) |
Opium fluid |
9620 |
(D) |
Powdered opium |
9639 |
(E) |
Granulated opium |
9640 |
(F) |
Tincture of opium |
9630 |
(G) |
Codeine |
9050 |
(H) |
Ethylmorphine |
9190 |
(I) |
Etorphine hydrochloride |
9059 |
(J) |
Hydrocodone |
9193 |
(K) |
Hydromorphone |
9150 |
(L) |
Metopon |
9260 |
(M) |
Morphine |
9300 |
(N) |
Noroxymorphone |
9668 |
(O) |
Oxycodone |
9143 |
(P) |
Oxymorphone |
9652 |
(Q) |
Thebaine |
9333 |
(R) |
Dihydroetorphine |
9334 |
(S) |
Oripavine |
9330 |
(2) Any salt, compound, isomer, derivative or preparation thereof which is chemically equivalent or identical with any of the substances referred to in paragraph (1), but not including the isoquinoline alkaloids of opium.
(3) Opium poppy and poppy straw.
(4) Coca leaves (9040) and any salt, compound, derivative or preparation of coca leaves, but not including decocainized coca leaves or extractions which do not contain cocaine (9041) or ecgonine (9180).
(5) Cocaine, its salts, isomers and salts of isomers (9041).
(6) Ecgonine, its salts, isomers and salts of isomers (9180).
(7) Concentrate of poppy straw (the crude extract of poppy straw in either liquid, solid or powder form which contains the phenanthrene alkaloids of the opium poppy) (9670).
(c) Any of the following opiates, including their isomers, esters, ethers, salts and salts of isomers, esters and ethers, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation dextrorphan and levopropoxyphene excepted:
(1) |
Alfentanil |
9737 |
(2) |
Alphaprodine |
9010 |
(3) |
Anileridine |
9020 |
(4) |
Bezitramide |
9800 |
(5) |
Bulk dextropropoxyphene (nondosage forms) |
9273 |
(6) |
Carfentanil |
9743 |
(7) |
Dihydrocodeine |
9120 |
(8) |
Diphenoxylate |
9170 |
(9) |
Fentanyl |
9801 |
(10) |
Isomethadone |
9226 |
(11) |
Levomethorphan |
9210 |
(12) |
Levorphanol |
9220 |
(13) |
Metazocine |
9240 |
(14) |
Methadone |
9250 |
(15) |
Methadone-intermediate, 4-cyano-2-dimethyl amino-4,4-diphenyl butane |
9254 |
(16) |
Moramide-intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid |
9802 |
(17) |
Oliceridine (N-[(3-methoxythiophen-2-yl)methyl]
|
9245 |
(18) |
Pethidine (meperidine) |
9230 |
(19) |
Pethidine-intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine |
9232 |
(20) |
Pethidine-intermediate-B, ethyl-4-phenyl-piperidine-4-carboxylate |
9233 |
(21) |
Pethidine-intermediate-C, 1-methyl-4-phenyl-piperidine-4-carboxylic acid |
9234 |
(22) |
Phenazocine |
9715 |
(23) |
Piminodine |
9730 |
(24) |
Racemethorphan |
9732 |
(25) |
Racemorphan |
9733 |
(26) |
Sufentanil |
9740 |
(27) |
Levo-alphacetyl methadol
|
9648 |
(28) |
Remifentanil |
9739 |
(29) |
Tapentadol |
9780 |
(30) |
Thiafentanil |
9729 |
(d) Any material, compound, mixture, or preparation which contains any quantity of the following substances having a potential for abuse associated with a stimulant effect on the central nervous system:
(1) |
Amphetamine, its salts, optical isomers and salts of its optical isomers |
1100 |
(2) |
Phenmetrazine and its salts |
1631 |
(3) |
Methamphetamine, including its salts, isomers and salts of isomers |
1105 |
(4) |
Methylphenidate |
1724 |
(5) |
Lisdexamfetamine, its salts, isomers, and salts of its isomers |
1205 |
(e) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers and salts of isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:
(1) |
Amobarbital |
2125 |
(2) |
Glutethimide |
2550 |
(3) |
Secobarbital |
2315 |
(4) |
Pentobarbital |
2270 |
(5) |
Phencyclidine |
7471 |
(f) Any material, compound, mixture, or preparation which contains any quantity of the following substances:
(1) |
Immediate precursor to amphetamine and methamphetamine: |
|
(A) Phenylacetone Some trade or other names: phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl ketone. |
8501 |
|
(2) |
Immediate precursors to phencyclidine (PCP): |
|
(A) 1-phenylcyclohexylamine |
7460 |
|
(B) 1-piperidinocyclohexanecarbonitrile (PCC) |
8603 |
|
(3) |
Immediate precursor to fentanyl: |
|
(A) 4-anilino-N-phenethylpiperidine (ANPP) |
8333 |
|
(B) N-phenyl-N-(piperidin-4-yl)propionamide
|
8366 |
(g) Any material, compound, mixture or preparation which contains any quantity of the following hallucinogenic substance, its salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:
(1) |
Dronabinol [(-)-delta-9-trans tetrahydrocannabinol] in an oral solution in a drug product approved for marketing by the United States food and drug administration |
7365 |
(2) |
Nabilone
|
7379 |
(h) Any material, compound, mixture or preparation containing any of the following narcotic drugs or any salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:
(1) |
Not more than 300 milligrams of dihydrocodeinone (hydrocodone) or any of its salts per 100 milliliters or not more than 15 milligrams per dosage unit with a fourfold or greater quantity of an isoquinoline alkaloid of opium |
9805 |
(2) |
Not more than 300 milligrams of dihydrocodeinone (hydrocodone) or any of its salts per 100 milliliters or not more than 15 milligrams per dosage unit with one or more active, nonnarcotic ingredients in recognized therapeutic amounts |
9806 |
History: L. 1972, ch. 234, § 7; L. 1974, ch. 258, § 3; L. 1978, ch. 257, § 1; L. 1980, ch. 195, § 2; L. 1982, ch. 269, § 3; L. 1985, ch. 220, § 2; L. 1986, ch. 241, § 2; L. 1987, ch. 244, § 2; L. 1989, ch. 200, § 2; L. 1991, ch. 199, § 2; L. 1992, ch. 174, § 2; L. 1994, ch. 54, § 2; L. 2000, ch. 108, § 2; L. 2011, ch. 83, § 4; L. 2015, ch. 27, § 2; L. 2017, ch. 57, § 5; L. 2018, ch. 101, § 2; L. 2022, ch. 99, § 4; June 9.
Revisor's Note:
Section was also amended by L. 2011, ch. 10, § 2, but that version was repealed by L. 2011, ch. 83, § 9.
Law Review and Bar Journal References:
"Methamphetamine, A Recipe for Disaster," Debra S. Peterson and R. Michael Jennings, 73 J.K.B.A. No. 9, 7, 46, 48 (2004).
"Bargaining for Freedom: Kansas Allows Criminal Defendants to Avoid Plea Agreement Sentences but Binds the State to Its Deals [State v. Boley, 113 P.3d 248 (Kan. 2005)]," Ali N. Ketchum, 45 W.L.J. 467 (2006).
Attorney General's Opinions:
Possession of methamphetamine; class C felony. 91-63.
CASE ANNOTATIONS
1. Conviction of conspiracy to deliver cocaine affirmed. State v. Glazer, 223 Kan. 351, 352, 574 P.2d 942.
2. Conviction of possession of a narcotic drug upheld even though no evidence was given that cocaine is a narcotic drug within the statutory definition. State v. Hermerding, 5 Kan. App. 2d 797, 798, 626 P.2d 210.
3. Conviction hereunder affirmed; proof of sale of any amount of a controlled substance sufficient to sustain conviction. State v. Loveland, 8 Kan. App. 2d 196, 198, 653 P.2d 472 (1982).
4. Specific intent to sell essential element of offering controlled substance for sale; failure of court to so instruct was error. State v. Werner, 8 Kan. App. 2d 364, 366, 657 P.2d 1136 (1983).
5. Purpose of act to control drug traffic; a controlled substance in a person's system is beyond control contemplated by act. State v. Flinchpaugh, 232 Kan. 831, 832, 833, 659 P.2d 208 (1983).
6. Cited; one trial tactical error by defendant's counsel not sufficient to show incompetent counsel. State v. Logan, 9 Kan. App. 2d 353, 354, 678 P.2d 181 (1984).
7. Cited; statutes describing possession and sale of material containing psilocybin (K.S.A. 65-4105, 65-4127b) not unconstitutionally vague. State v. Justice, 10 Kan. App. 2d 569, 572, 577, 704 P.2d 1012 (1985).
8. Conviction hereunder; issue of sentencing under K.S.A. 21-4606a as first-time offender discussed. State v. Linsin, 10 Kan. App. 2d 681, 709 P.2d 988 (1985).
9. Cited; amphetamine and methamphetamine as different substances supporting different crimes examined. State v. McMannis, 12 Kan. App. 2d 464, 747 P.2d 1343 (1987).
10. Exclusion of evidence on grounds of remoteness that substantially impairs state's case examined. State v. Griffin, 246 Kan. 320, 787 P.2d 701 (1990).
11. Conviction reversed where crime charged not crime committed; cunnilingus as not sodomy (K.S.A. 21-3506) nor incest (K.S.A. 21-3602) noted. State v. Schad, 247 Kan. 242, 246, 795 P.2d 406 (1990).
12. Amendments to sentencing statutes regarding modification (K.S.A. 21-4603(3)(a)) and presumption of probation (K.S.A. 21-4606a) as substantive and applicable prospectively determined. State v. Sylva, 14 Kan. App. 2d 609, 610, 795 P.2d 947 (1990); affirmed 248 Kan. 118, 804 P.2d 967 (1991).
13. Whether intercepted conversations should be suppressed because they were unrelated to offenses described in wiretap application examined. State v. Gibson, 255 Kan. 474, 491, 874 P.2d 1122 (1994).
14. Criminal convictions hereunder; court discusses grounds to uphold warrantless searches. State v. Geraghty, 38 Kan. App. 2d 114, 117, 163 P.3d 350 (2007).
15. Cited in case declaring probation a permissible sentence for conspiracy to unlawfully manufacture methamphetamine. State v. Moffit, 38 Kan. App. 2d 414, 166 P.3d 435 (2007).
16. Mentioned in discussion that methamphetamine is a controlled substance. State v. Spangler, 38 Kan. App. 2d 817, 833, 173 P.3d 656 (2008).
17. Convictions hereunder reversed; failure to admit certain evidence and limiting cross examination by defense counsel held reversible error. State v. Scott, 39 Kan. App. 2d 49, 50, 52, 177 P.3d 972 (2008).
18. Constructive possession principles discussed and applied; no probable cause found. State v. Beaver, 41 Kan. App. 2d 124, 200 P.3d 490 (2009).
19. Conviction hereunder upheld; traffic stop and smell of marijuana provided probable cause for search. State v. Preston, 41 Kan. App. 2d 981, 207 P.3d 1081 (2009).
20. Possession of the narcotic in Lortab is a felony under K.S.A. 65-4160. State v. Surowski, 42 Kan. App. 2d 304, 212 P.3d 229 (2009).
LEGISLATIVE COORDINATING COUNCIL
10/23/2024
Meeting Notice
09/09/2024 Meeting Notice Agenda 08/21/2024 Meeting Notice Agenda LCC Policies REVISOR OF STATUTES
Chapter 72 Statute Transfer List
Kansas School Equity & Enhancement Act Gannon v. State A Summary of Special Sessions in Kansas Bill Brief for Senate Bill No. 1 Bill Brief for House Bill No. 2001 2024 Amended & Repealed Statutes 2023 Amended & Repealed Statutes 2022 Amended & Repealed Statutes 2021 Amended & Repealed Statutes USEFUL LINKS
Session Laws
OTHER LEGISLATIVE SITES
Kansas LegislatureAdministrative Services Division of Post Audit Research Department |